BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1912612)

  • 1. Estrone sulfatase activity and effect of antiestrogens on transformation of estrone sulfate in hormone-dependent vs. independent human breast cancer cell lines.
    Pasqualini JR; Nguyen BL
    Breast Cancer Res Treat; 1991 May; 18(2):93-8. PubMed ID: 1912612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Effect of antiestrogens.
    Pasqualini JR; Gelly C; Nguyen BL
    Ann N Y Acad Sci; 1990; 595():106-16. PubMed ID: 2375600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer.
    Pasqualini JR; Schatz B; Varin C; Nguyen BL
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):323-9. PubMed ID: 1580921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of estrogen sulfates in breast cancer.
    Pasqualini JR; Gelly C; Nguyen BL; Vella C
    J Steroid Biochem; 1989; 34(1-6):155-63. PubMed ID: 2560511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).
    Nguyen BL; Chetrite G; Pasqualini JR
    Breast Cancer Res Treat; 1995 May; 34(2):139-46. PubMed ID: 7647331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of promegestone, tamoxifen, 4-hydroxytamoxifen and ICI 164,384 on the oestrone sulphatase activity of human breast cancer cells.
    Chetrite G; Varin C; Delalonde L; Pasqualini JR
    Anticancer Res; 1993; 13(4):931-4. PubMed ID: 8352561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
    Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
    Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
    Selcer KW; Jagannathan S; Rhodes ME; Li PK
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer of the breast, mechanism of action of anti-estrogens].
    Pasqualini JR; Gelly C
    Pathol Biol (Paris); 1988 Oct; 36(8):979-82. PubMed ID: 3059288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells.
    Nguyen BL; Ferme I; Chetrite G; Pasqualini JR
    J Steroid Biochem Mol Biol; 1993 Jul; 46(1):17-23. PubMed ID: 8338787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of estrone, estradiol, and estrone sulfate in uterine and vaginal isolated cells of fetal guinea pig. Effect of various antiestrogens in the conversion of estrone sulfate to estradiol.
    Urabe M; Chetrite G; Pasqualini JR
    Steroids; 1993 May; 58(5):209-14. PubMed ID: 8356572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
    Selcer KW; Hegde PV; Li PK
    Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of sulfatase and sulfotransferase activities by medrogestone in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines.
    Chetrite GS; Ebert C; Wright F; Philippe AC; Pasqualini JR
    J Steroid Biochem Mol Biol; 1999; 70(1-3):39-45. PubMed ID: 10529001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines.
    Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
    Anticancer Res; 1999; 19(1A):269-75. PubMed ID: 10226553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues.
    Chetrite GS; Cortes-Prieto JC; Philippe JC; Pasqualini JR
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):289-92. PubMed ID: 17481887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence.
    Pasqualini JR; Chetrite G; Nguyen BL; Maloche C; Delalonde L; Talbi M; Feinstein MC; Blacker C; Botella J; Paris J
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):407-12. PubMed ID: 7626488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
    Lykkesfeldt AE; Larsen SS; Briand P
    Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.